Virax Biolabs Group Limited Director Resignation and Appointment


SEC Filing 6-K (0000950170-25-100244)


On July 28, 2025, Mr. Yair Erez resigned as an independent director of Virax Biolabs Group Limited to focus on other professional endeavors. His resignation was not due to any disagreement with the company. On the same day, the Board appointed Dr. Iain Miller to fill the vacancy. Dr. Miller brings over 30 years of executive-level experience, particularly in the in-vitro diagnostic and precision medicine sectors. He has held various leadership roles, including CEO positions at SAW Diagnostics and Presymptom Health. Dr. Miller also serves as a non-executive board director of Pictura Bio. He holds an MBA, a Ph.D. in BioEngineering, and a B.S. in Physics/Engineering. Dr. Miller was appointed to the Compensation Committee, Nominating and Corporate Governance Committee, and Audit Committee. His appointment was not part of any arrangement or understanding with other persons, and he has no family relationships with any executive officers or directors of the company.


Tickers mentioned in this filing:VRAX

TradeFomo: SEC Filing 6-K (0000950170-25-100244) for VRAX